化工儀器網(wǎng)>產(chǎn)品展廳>試劑標(biāo)物>行業(yè)專用試劑>生化與分子生物學(xué)用試劑>abs00915 Recombinant Human IFN-α2b, Yeast
abs00915 Recombinant Human IFN-α2b, Yeast
參考價 | ¥ 720 |
訂貨量 | ≥1 |
具體成交價以合同協(xié)議為準
- 公司名稱 愛必信(上海)生物科技有限公司
- 品牌 absin
- 型號 abs00915
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/7/28 19:29:09
- 訪問次數(shù) 1344
產(chǎn)品標(biāo)簽
聯(lián)系方式:愛必信18438616290 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
供貨周期 | 一周 | 規(guī)格 | 20ug |
---|
概述 | |
---|---|
形態(tài) | Lyophilized from a 0.2 µm filtered solution in PBS, pH 7.4, with 0.02 % Tween-20. |
來源 | Yeast |
氨基酸序列 | CDLPQTHSLG SRRTLMLLAQ MRRISLFSCL KDRHDFGFPQ EEFGNQFQKA ETIPVLHEMI IFNLFSTK DSSAAWDETL LDKFYYLNDLEACVI QGVGVTETPL MKEDSILAVR KYFQRITLYL KEKKYSPCAW EVVRAEIMRS FSLSTNLQES LRSKE |
內(nèi)毒素水平 | Less than 0.1 EU/µg of Recombinant HumanIFN-α2b, Yeast as determined by LAL method. |
活性 | Fully biologically active when compared to standard. The specific activity determined by an anti-viral assay is no less than 1.6 × 108 IU/mg. |
Accession # | P01563 |
預(yù)期分子量 | Approximay 19.3 kDa, a single polypeptide chain containing 165 amino acids. |
性能 | |
---|---|
溶解方法 | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
保存方法 | This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
純度 | > 98 % by SDS-PAGE and HPLC analyses. |
Gene IDs | 3440 |
參考文獻 | |
---|---|
1. Tarhini AA, Gogas H, Kirkwood JM. 2012. J Immunol, 189: 3789-93.<br/>2. Tohyama M, Yang L, Hanakawa Y, et al. 2012. J Invest Dermatol, 132: 1933-5.<br/>3. Corssmit EP, Heijligenberg R, Hack CE, et al. 1997. Clin Exp Immunol, 107: 359-63.<br/>4. Corssmit EP, de Metz J, Sauerwein HP, et al. 2000. J Interferon Cytokine Res, 20: 1039-47. |